This session highlights emerging advances at the intersection of cardiovascular, renal, and metabolic medicine. Leading experts review emerging therapies in heart failure, kidney and metabolic diseases. They examine the expanding role of incretin-based therapies in shaping cardiorenal outcomes, and provide insights into the aldosterone pathway, outlining novel approaches for managing hypertension.